Compare · STAA vs WRBY
STAA vs WRBY
Side-by-side comparison of STAAR Surgical Company (STAA) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both STAA and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- WRBY is the larger of the two at $3.04B, about 2.7x STAA ($1.12B).
- STAA has been more active in the news (4 items in the past 4 weeks vs 3 for WRBY).
- Both have 25 recent analyst ratings on file.
- Company
- STAAR Surgical Company
- Warby Parker Inc.
- Price
- $21.27-4.45%
- $23.34-5.06%
- Market cap
- $1.12B
- $3.04B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 4
- 3
- Recent ratings
- 25
- 25
STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest STAA
- STAAR Surgical Names Andrew Pilon as Vice President of Business Development
- Amendment: STAAR Surgical Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- STAAR Surgical upgraded by Stifel with a new price target
- STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
- STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
- STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
- Chief Development Officer Michna Magda exercised 6,599 shares at a strike of $4.36 and covered exercise/tax liability with 3,356 shares, increasing direct ownership by 9% to 41,343 units (SEC Form 4)
- Chief Financial Officer & EVP Andrews Deborah J converted options into 5,233 shares and covered exercise/tax liability with 2,662 shares, increasing direct ownership by 7% to 38,910 units (SEC Form 4)
- President and CEO Foust Warren converted options into 10,997 shares and covered exercise/tax liability with 5,595 shares, increasing direct ownership by 11% to 95,816 units (SEC Form 4)
- SEC Form 10-Q filed by STAAR Surgical Company
Latest WRBY
- Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026
- Director Raider Jeffrey Jacob sold $415,500 worth of shares (15,000 units at $27.70) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 420,201 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 95,614 shares and sold $2,769,000 worth of shares (100,000 units at $27.69) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 36,020 units (SEC Form 4)
- Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference
- Co-Chief Executive Officer Gilboa David Abraham covered exercise/tax liability with 11,504 shares and converted options into 20,798 shares, increasing direct ownership by 30% to 40,406 units (SEC Form 4) (tax liability)
- Co-Chief Executive Officer Blumenthal Neil Harris covered exercise/tax liability with 11,504 shares and converted options into 20,798 shares, increasing direct ownership by 30% to 40,406 units (SEC Form 4) to cover taxes
- SEC Form 10-Q filed by Warby Parker Inc.
- Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Warby Parker Announces Second Quarter 2026 Results
- Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026